Search Results 1281-1290 of 21396 for anti-TNF drugs

  1. Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used after an initial treatment plan to treat HER2-positive early breast cancer which has a high risk of occurring again.

  2. Tuberculin (Intradermal Route) Precautions - Mayo Clinic

    Make sure your doctor knows if you are using a medicine that weakens your immune system, such as a steroid or cancer treatment. Tuberculin skin test should not ...

  3. Tegaserod (Oral Route) Description and Brand Names - Mayo Clinic

    Your doctor will then contact FDA's Division for Drug Information about the emergency IND process at druginfo@fda.hhs.gov. This medicine is available only with ...

  4. Telmisartan And Hydrochlorothiazide (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Micardis HCT. Descriptions. Telmisartan and ...

  5. Flurbiprofen (Oral Route) Before Using - Mayo Clinic

    ... drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the ...

  6. Neomycin, Polymyxin B, And Hydrocortisone (Otic Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis - Mayo Clinic

    ... (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti-TNF agents in patients with TA that was not controlled by ...

  8. Dactinomycin (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Consensus reached on initial treatment of acute graft-versus-host disease in patients who receive bone marrow transplant; nothing definitive yet for secondary treatment - Mayo Clinic

    There are now two approved second line therapies for treatment of steroid-refractory GVHD ― one for acute GVHD and one for chronic GVHD.

  10. Rheumatology - Conditions treated - Mayo Clinic

    Mayo Clinic rheumatologists have expertise in the treatment of inflammatory diseases of blood vessels (vasculitis) and systemic autoimmune connective tissue ...